J. Kevin Buchi
2019
In 2019, J. Kevin Buchi earned a total compensation of $1.9M as Former Chief Executive Officer at BioSpecifics Technologies.
Compensation breakdown
| Non-Equity Incentive Plan | $90,000 |
|---|---|
| Option Awards | $1,620,100 |
| Salary | $138,636 |
| Other | $6,383 |
| Total | $1,855,119 |
Buchi received $1.6M in option awards, accounting for 87% of the total pay in 2019.
Buchi also received $90K in non-equity incentive plan, $138.6K in salary and $6.4K in other compensation.
Rankings
In 2019, J. Kevin Buchi's compensation ranked 6,320th out of 13,971 executives tracked by ExecPay. In other words, Buchi earned more than 54.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,320 out of 13,971 | 55th |
Division Manufacturing | 2,379 out of 5,695 | 58th |
Major group Chemicals And Allied Products | 868 out of 2,194 | 60th |
Industry group Drugs | 735 out of 1,880 | 61st |
Industry Pharmaceutical Preparations | 544 out of 1,392 | 61st |
Source: SEC filing on April 29, 2020.
Buchi's colleagues
We found three more compensation records of executives who worked with J. Kevin Buchi at BioSpecifics Technologies in 2019.
2019
Patrick Caldwell
BioSpecifics Technologies
Former Interim Principal Financial Officer
2019
Thomas Wegman
BioSpecifics Technologies
Former President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
2019
Ronald Law
BioSpecifics Technologies